Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer obtains FDA complete response letter for osteoporosis drug
Pfizer is reviewing the letter and will work with the FDA to determine the appropriate next steps regarding the company’s application. Pfizer has submitted the current application for
Pfizer is reviewing the letter and will work with the FDA to determine the appropriate next steps regarding the company’s application. Pfizer has submitted the current application for
Advanced Medical Optics’s (AMO) Tecnis multifocal intraocular lens (IOL) are indicated for primary implantation for the visual correction of aphakia in adult patients with and without presbyopia in
Lupin’s levetiracetam tablets are the AB-rated generic equivalent of UCB Pharmaceuticals’s Keppra tablets, indicated as adjunctive therapy in the treatment of certain types of seizures associated with epilepsy.
Prior to Roche, he worked at other diagnostic and medical device companies including Organon Teknika (bioMerieux), Amersham, Biotech Research Laboratories and others. He holds a Bachelor of Science
The company said that it has significantly expanded its worldwide operational infrastructure and is now adding a corresponding upgrade to its business development functions. Mr Thompson will lead
Most recently, Dr Zelenkofske served as vice president of cardiovascular and thrombosis medical unit for US at Sanofi-Aventis Pharmaceuticals and, prior to this, as vice president of clinical
In the study, an HIV-infected individual recently initiated treatment with the Aethlon Hemopurifier as part of a 30-day case study being conducted at the Jattinder Gambhir Hospital in
In a separate but related agreement, the MPM Bio IV NVS Strategic Fund made an equity investment in Peptimmune. In the event that Novartis exercises the option to
Ms Hoppe is responsible for managing the company’s information technology initiatives and integrating technology solutions with business processes on a global basis. Prior to joining Parexel, Ms Hoppe
Developed in ViraCor’s laboratories, the molecular test accurately detects key genetic mutations associated with antiviral resistance in cytomegalovirus (CMV) in three days or less, the company said. Turnaround